GlassScriptPhysician profile
Bushra I Malik
NPI 1891962999
$4,925.39
in general payments reported to CMS, 2019-2025
20 companies · $1,720 in 2025
The $1,720 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $262 · 2020: $16.96 · 2021: $105 · 2022: $872 · 2023: $1,191 · 2024: $758 · 2025: $1,720.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,669.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,668.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,305.99 | 2021-2025 | |
| Impel Pharmaceuticals INC. | $446.62 | 2022-2023 | Trudhesa |
| Lundbeck LLC | $307.25 | 2022-2025 | Vyepti |
| Amgen INC. | $272.07 | 2021-2024 | Aimovig |
| Axsome Therapeutics, INC. | $247.36 | 2025 | Symbravo |
| Pfizer INC. | $225.96 | 2023-2025 | |
| Teva Pharmaceuticals USA, INC. | $213.43 | 2019-2024 | Austedo Xr, Austedo, Ajovy |
| Merz Pharmaceuticals, LLC | $138.93 | 2022-2025 | Xeomin, Inbrija |
| Lilly USA, LLC | $138.14 | 2022 | |
| Impel Pharmaceuticals LLC | $133.08 | 2025 | Trudhesa |
| Allergan, INC. | $124.80 | 2019 | |
| Sk Life Science, INC. | $124.00 | 2024 | Xcopri |
| Eisai INC. | $52.97 | 2022-2023 | |
| Ipsen Biopharmaceuticals, INC | $43.92 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $41.44 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tonix Medicines, INC. | $33.35 | 2025 | Zembrace Symtouch |
| Upsher-Smith Laboratories LLC | $27.85 | 2023 | |
| Collegium Pharmaceutical, INC. | $18.59 | 2022 | |
| Sunovion Pharmaceuticals INC. | $16.96 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.68 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bushra Malik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.